{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:11:19Z","timestamp":1793045479720,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970726"],"award-info":[{"award-number":["81970726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbadis.2025.167750","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:19:50Z","timestamp":1740770390000},"page":"167750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Farnesoid X receptor activation alleviates hepatic encephalopathy by improving hepatic ammonia metabolism in murine models"],"prefix":"10.1016","volume":"1871","author":[{"given":"Wenling","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.bbadis.2025.167750_bb0005","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMra1600561","article-title":"Hepatic encephalopathy","volume":"375","author":"Wijdicks","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167750_bb0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00005792-200205000-00007","article-title":"Hyperammonemic encephalopathy","volume":"81","author":"Brusilow","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167750_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1665-2681(19)32137-4","article-title":"Hepatic encephalopathy: a review","volume":"2","author":"Lizardi-Cervera","year":"2003","journal-title":"Ann. Hepatol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167750_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cld.2020.01.004","article-title":"Prognosis of hepatic encephalopathy","volume":"24","author":"Krishnarao","year":"2020","journal-title":"Clin. Liver Dis."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167750_bb0025","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/liv.13752","article-title":"Hepatic encephalopathy: diagnosis and management","volume":"38","author":"Amodio","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2025.167750_bb0030","series-title":"The Complex Interplay Between Gut-brain, Gut-liver, and Liver-brain Axes","first-page":"159","article-title":"Gut\u2013liver\u2013brain axis in chronic liver disease with a focus on hepatic encephalopathy","author":"de la Vera","year":"2021"},{"key":"10.1016\/j.bbadis.2025.167750_bb0035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2025.167750_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.acc.2014.09.002","article-title":"Ammonia metabolism and hyperammonemic disorders","volume":"67","author":"Walker","year":"2014","journal-title":"Adv. Clin. Chem."},{"issue":"11","key":"10.1016\/j.bbadis.2025.167750_bb0045","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bbadis.2011.06.009","article-title":"The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate","volume":"1812","author":"Renga","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2025.167750_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115074","article-title":"Amino acid metabolism, transport and signalling in the liver revisited","volume":"201","author":"Paulusma","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167750_bb0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biocel.2006.10.007","article-title":"Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2","volume":"39","author":"Mavri-Damelin","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"11","key":"10.1016\/j.bbadis.2025.167750_bb0060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/13543776.2018.1527906","article-title":"FXR modulators for enterohepatic and metabolic diseases","volume":"28","author":"Wang","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167750_bb0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1534-5807(02)00154-5","article-title":"Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis","volume":"2","author":"Kerr","year":"2002","journal-title":"Dev. Cell"},{"issue":"6","key":"10.1016\/j.bbadis.2025.167750_bb0070","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1534-5807(02)00187-9","article-title":"Redundant pathways for negative feedback regulation of bile acid production","volume":"2","author":"Wang","year":"2002","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167750_bb0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167750_bb0080","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism","volume":"25","author":"Claudel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5771","key":"10.1016\/j.bbadis.2025.167750_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1121435","article-title":"Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration","volume":"312","author":"Huang","year":"2006","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167750_bb0090","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","article-title":"The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis","volume":"127","author":"Fiorucci","year":"2004","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bbadis.2025.167750_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013955","article-title":"Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand","volume":"5","author":"Li","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167750_bb0100","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bbadis.2025.167750_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023745","article-title":"Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease","volume":"6","author":"Nijmeijer","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167750_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/aps.2014.117","article-title":"FXR and liver carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167750_bb0115","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1053\/j.gastro.2017.01.014","article-title":"Farnesoid X receptor activation promotes hepatic amino acid catabolism and ammonium clearance in mice","volume":"152","author":"Massafra","year":"2017","journal-title":"Gastroenterology"},{"issue":"10215","key":"10.1016\/j.bbadis.2025.167750_bb0120","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.bbadis.2025.167750_bb0125","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbadis.2011.03.009","article-title":"Proteomics for the discovery of nuclear bile acid receptor FXR targets","volume":"1812","author":"Gardmo","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2025.167750_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbrc.2022.04.073","article-title":"FXR\/ASS1 axis attenuates the TAA-induced liver injury through arginine metabolism","volume":"611","author":"Hong","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167750_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcmgh.2018.02.008","article-title":"FXR-mediated cortical cholesterol accumulation contributes to the pathogenesis of type a hepatic encephalopathy","volume":"6","author":"McMillin","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167750_bb0140","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.14309\/01.ajg.0000582220.94404.5a","article-title":"Attenuation of neurological symptoms of type C hepatic encephalopathy by selective ablation of neuronal FXR expression","volume":"114","author":"Grant","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167750_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jceh.2018.04.011","article-title":"Bile acids in hepatic encephalopathy","volume":"9","author":"DeMorrow","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167750_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2144\/000114450","article-title":"Reuse of E-plate cell sensor arrays in the xCELLigence real-time cell analyzer","volume":"61","author":"Stefanowicz-Hajduk","year":"2016","journal-title":"Biotechniques"},{"key":"10.1016\/j.bbadis.2025.167750_bb0155","article-title":"Identification of CBPA as a new inhibitor of PD-1\/PD-L1 interaction","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167750_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/08941930390194424","article-title":"Partial hepatectomy in the mouse: technique and perioperative management","volume":"16","author":"Greene","year":"2003","journal-title":"J. Investig. Surg."},{"issue":"138","key":"10.1016\/j.bbadis.2025.167750_bb0165","first-page":"S","article-title":"Farnesoid X receptor regulates glutamate metabolism: relevance for hepatic encephalopathy","volume":"5","author":"Renga","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.bbadis.2025.167750_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166133","article-title":"FXR in liver physiology: multiple faces to regulate liver metabolism","volume":"1867","author":"Panzitt","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167750_bb0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2005.07.008","article-title":"Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice","volume":"21","author":"Avraham","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167750_bb0180","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/hpb.12465","article-title":"Characterization of a porcine model for associating liver partition and portal vein ligation for a staged hepatectomy","volume":"17","author":"Croome","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167750_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e318265fd51","article-title":"Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"256","author":"Narita","year":"2012","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167750_bb0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/lt.25420","article-title":"Neurological complications occurring after liver transplantation: role of risk factors, hepatic encephalopathy, and acute (on chronic) brain injury","volume":"25","author":"Weiss","year":"2019","journal-title":"Liver Transpl."},{"issue":"5","key":"10.1016\/j.bbadis.2025.167750_bb0195","first-page":"238","article-title":"Post-hepatectomy liver failure","volume":"3","author":"Kauffmann","year":"2014","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167750_bb0200","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/nm.3400","article-title":"Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering","volume":"19","author":"Rangroo Thrane","year":"2013","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167750_bb0205","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.apsb.2018.11.004","article-title":"Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis","volume":"9","author":"Zhou","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbadis.2025.167750_bb0210","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.biopha.2017.11.083","article-title":"Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation","volume":"96","author":"Xiong","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2025.167750_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122355","article-title":"Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury","volume":"337","author":"Lu","year":"2024","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167750_bb0220","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","article-title":"Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure","volume":"62","author":"Romero-G\u00f3mez","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167750_bb0225","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jceh.2014.06.004","article-title":"Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation","volume":"5","author":"Aldridge","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167750_bb0230","series-title":"Microglia-mediated Neuroinflammation in Neurodegenerative Diseases[C]\/\/Seminars in Cell & Developmental Biology","first-page":"112","volume":"94","author":"Subhramanyam","year":"2019"},{"issue":"2","key":"10.1016\/j.bbadis.2025.167750_bb0235","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/glia.22930","article-title":"Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge","volume":"64","author":"Norden","year":"2016","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167750_bb0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2025.167750_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176334","article-title":"Farnesoid X receptor agonist tropifexor detoxifies ammonia by regulating the glutamine metabolism and urea cycles in cholestatic livers","volume":"966","author":"Xiao","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbadis.2025.167750_bb0250","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.bbadis.2010.12.006","article-title":"Nuclear bile acid receptor FXR in the hepatic regeneration","volume":"1812","author":"Chen","year":"2011","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2025.167750_bb0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fnbeh.2015.00070","article-title":"Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior","volume":"9","author":"Huang","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbadis.2025.167750_bb0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2017.00191","article-title":"Bile acid-mediated sphingosine-1-phosphate receptor 2 signaling promotes neuroinflammation during hepatic encephalopathy in mice","volume":"11","author":"McMillin","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2025.167750_bb0265","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ebiom.2018.10.030","article-title":"Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure","volume":"37","author":"Xie","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbadis.2025.167750_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114673","article-title":"Tadalafil restores long-term memory and synaptic plasticity in mice with hepatic encephalopathy","volume":"379","author":"Franca","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167750_bb0275","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/bit.22799","article-title":"Effects of glucose and insulin on HepG2-C3A cell metabolism","volume":"107","author":"Iyer","year":"2010","journal-title":"Biotechnol. Bioeng."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167750_bb0280","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jhep.2022.07.014","article-title":"Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis","volume":"77","author":"Tranah","year":"2022","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167750_bb0285","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/hep.21838","article-title":"Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure","volume":"46","author":"Bernal","year":"2007","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.bbadis.2025.167750_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082312","article-title":"Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting","volume":"8","author":"Selden","year":"2013","journal-title":"PLoS One"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392500095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392500095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:25:17Z","timestamp":1762323917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392500095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S092544392500095X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167750","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farnesoid X receptor activation alleviates hepatic encephalopathy by improving hepatic ammonia metabolism in murine models","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167750"}}